Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $2.9 million.

  • Palisade Bio's Operating Expenses fell 1867.52% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year decrease of 2169.37%. This contributed to the annual value of $14.9 million for FY2024, which is 1155.41% up from last year.
  • According to the latest figures from Q3 2025, Palisade Bio's Operating Expenses is $2.9 million, which was down 1867.52% from $2.8 million recorded in Q2 2025.
  • Palisade Bio's 5-year Operating Expenses high stood at $32.9 million for Q2 2021, and its period low was $2.0 million during Q1 2021.
  • Moreover, its 5-year median value for Operating Expenses was $3.6 million (2022), whereas its average is $5.0 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 168479.09% in 2021, then tumbled by 8912.9% in 2022.
  • Quarter analysis of 5 years shows Palisade Bio's Operating Expenses stood at $3.0 million in 2021, then grew by 27.59% to $3.8 million in 2022, then dropped by 18.04% to $3.2 million in 2023, then rose by 7.23% to $3.4 million in 2024, then fell by 13.6% to $2.9 million in 2025.
  • Its Operating Expenses was $2.9 million in Q3 2025, compared to $2.8 million in Q2 2025 and $2.3 million in Q1 2025.